Navigation Links
PAL-MED CONNECT partners with Briefings in Palliative, Hospice, and Pain Medicine & Management
Date:10/4/2010

New Rochelle, NY, October 4, 2010 Briefings in Palliative, Hospice, and Pain Medicine & Management, the e-newsletter companion to Journal of Palliative Medicine published by Mary Ann Liebert, Inc. (www.liebertpub.com), is pleased to announce a collaboration with The Institute for Palliative Medicine's (www.palliativemed.org) PAL-MED CONNECT (http://palmedconnect.org/) hotline to create a new monthly feature for the e-newsletter. Each month, Briefings will now include a valuable case study focusing on patients with advanced pain and symptom management challenges, or chronic or life-threatening illness.

Briefings will present practical, clinical case studies encountered by callers to PAL-MED CONNECT. Anticipated subjects include pain management, safety and efficacy of opioids, opioid conversion, neuropathic pain symptoms, difficult family conversations, decision-making about NG tubes, and other key topics. The studies will initially appear on the last Wednesday of each month with the potential for them to appear more frequently based on reader response. The first case study (http://www.liebertpub.com/palliative/archive/2010/Sept_10/Sept_29_10.htm) was published on September 29, 2010.

The PAL-MED CONNECT hotline is a grant-funded hotline that provides free access for healthcare professionals seeking expertise and educational resources related to palliative care and complex symptom management. The hotline can be accessed by physicians, physician assistants, nurse practioners, pharmacists, nurses, and other healthcare professionals. Callers speak directly clinician to expert clinician, at no charge. The hotline is available at 1-877-PAL-MED4.

"This California based hotline is gaining attention from healthcare professionals nationwide. Healthcare professionals utilize the hotline when complex symptoms arise. We provide them with information on options for care and evidence based resources," states Charles von Gunten, MD, PhD, Provost of The Institute for Palliative Medicine.


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Related biology news :

1. Connection between light at night and cancer revealed in additional study
2. Connection between light at night (LAN) and cancer revealed in additional study
3. Cactus genes connect modern Mexico to its prehistoric past
4. Researchers connect APC protein to autism and mental retardation
5. Brain connections break down as we age
6. Greenhouse gas calculator connects farming practices with carbon credits
7. Calcium connections: Basic pathway for maintaining cells fuel stores
8. Searching for causes of neural disconnection in schizophrenia
9. Connecting the dots: How light receptors get their message across
10. Connection elucidated between obesity, salt sensitivity and high blood pressure
11. Biomatrica Launches New Partnership Program - Biomatrica Connect(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PAL-MED CONNECT partners with Briefings in Palliative, Hospice, and Pain Medicine & Management
(Date:11/22/2016)... , Nov. 22, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... LiveWire Healthcare and Life Sciences Awards as "Most ... off an unprecedented year of recognition and growth for ... over 15 years. iMedNet ™ ...
(Date:11/17/2016)... Market Watch: Primarily supported by ownership types; Private ... market is to witness a value of US$37.1 billion by ... Annual Growth Rate (CAGR) of 10.75% is foreseen from ... North America is not way behind ... at 9.56% respectively. Report Focus: The ...
(Date:11/15/2016)...  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... gut microbiome, today announced the pricing of an ... common stock and warrants to purchase 50,000,000 shares ... the public of $1.00 per share and accompanying ... offering, excluding the proceeds, if any from the ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... CA (PRWEB) , ... December 01, 2016 , ... ACEA ... from its Phase I/II clinical trials for AC0010 at the World Conference on Lung ... to providing an update on the phase I/II clinical trials for AC0010 in patients ...
(Date:12/2/2016)... KING OF PRUSSIA, PA (PRWEB) , ... December 01, 2016 , ... ... clinical research is through industry-wide collaboration, standardization and a beautiful technology experience. All three ... which convened more than 100 clinical trial leaders from over 40 sponsor, CRO and ...
(Date:12/2/2016)... -- The immunohistochemistry (IHC) market is projected to ... 7.3% during the forecast period of 2016 to 2021 dominated by ... for the largest share of immunohistochemistry (IHC) market, by end user. ... , , ... spread across 225 pages, profiling 10 companies and supported with 181 ...
(Date:11/30/2016)... , Nov. 30, 2016 /PRNewswire/ - Portage Biotech ... Securities Exchange: PBT.U), is excited to announce the ... focused on developing preclinical ophthalmology assets through proof ... potent anti-inflammatory created by Portage Pharmaceuticals Limited and ... with ocular surface and anterior segment diseases. This ...
Breaking Biology Technology: